TD SYNNEX Corp reported an insider transaction by a director involving a small sale of common stock. On 12/04/2025, the director sold 168 shares of TD SYNNEX common stock at a price of $153.38 per share, coded as an open-market sale. After this transaction, the director beneficially owns 7,162 shares, held directly. The filing notes that these sales were carried out under a Rule 10b5-1 trading plan adopted on August 2, 2025, which is a pre-arranged plan designed to allow insiders to trade shares according to preset instructions.
TD SYNNEX reported insider stock sales by a director and Hyve Solutions executive. On 12/04/2025, a total of 3,000 shares of common stock were sold in several transactions by a family trust, all coded as open-market sales. The shares were sold at weighted average prices of $154.47, $155.72, and $156.01, with underlying trade prices ranging from $154.17 to $155.91.
The filing notes these transactions were made under a Rule 10b5-1 trading plan adopted on October 13, 2024 for the Polk family trust, of which the insider is a trustee. After these sales, the trust indirectly holds 75,660 shares, and the insider directly holds an additional 34,099 shares of TD SYNNEX common stock.
TD SYNNEX (SNX) has a notice of proposed insider sale under Rule 144 for 5,853 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $901,420.53. These shares were acquired as restricted stock units from the issuer on 01/24/2023, with the same date listed as the payment date.
The filing also lists recent sales of TD SYNNEX common stock over the past three months for the same account group: 3,000 shares sold on 11/04/2025 for gross proceeds of $451,697.45, 17,500 shares sold on 10/09/2025 for $2,738,783.60, and 3,000 shares sold on 10/06/2025 for $477,258.30. The issuer reports 81,437,855 shares of common stock outstanding.
TD SYNNEX Corp director reports planned stock sales under Rule 10b5-1 plan. A board member of TD SYNNEX Corp (ticker SNX) filed details of two open-market sales of common stock dated 12/01/2025. The reporting person sold 2,438 shares at a weighted average price of $151.72 and 2,562 shares at a weighted average price of $152.48, both marked as disposition transactions.
The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on July 14, 2025, which is designed to allow pre-arranged trading while addressing insider trading concerns. After these sales, the director beneficially owns 52,515 shares of TD SYNNEX common stock directly. The filing notes that the price figures represent weighted averages across multiple trades within stated price ranges and that full price breakdowns are available upon request.
TD SYNNEX (SNX) director and Hyve Solutions executive reported open‑market sales totaling 3,000 shares on 11/04/2025 under a Rule 10b5-1 trading plan adopted on October 13, 2024. The trust sold 600 shares at a weighted average price of $149.81 (range $149.50–$149.99), 1,761 shares at $150.59 (range $150.05–$150.99), and 639 shares at $151.21 (range $151.07–$151.36).
Following the transactions, beneficial ownership stood at 78,660 shares held indirectly by a trust and 34,099 shares held directly.
TD SYNNEX (SNX): FMR LLC filed an amended Schedule 13G reporting a passive beneficial ownership of 6,482,929.92 shares of TD SYNNEX common stock, representing 7.9% of the class as of 09/30/2025. FMR reports sole voting power over 6,454,541.96 shares and sole dispositive power over 6,482,929.92 shares, with no shared voting or dispositive power.
Abigail P. Johnson is also a reporting person, listing sole dispositive power over 6,482,929.92 shares and no voting power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. It notes that one or more other persons may have rights to receive dividends or sale proceeds, with no single such interest exceeding five percent of the total outstanding common stock.
TD SYNNEX (SNX) reported an insider transaction by a director. On 11/03/2025, the reporting person sold 336 shares of common stock at $155.79 per share, executed under a Rule 10b5-1 trading plan adopted on August 2, 2025. Following the sale, the insider beneficially owns 7,330 shares directly.
TD SYNNEX (SNX) reported an insider transaction: a director sold a total of 5,000 shares of common stock on 11/03/2025 pursuant to a Rule 10b5-1 trading plan adopted on July 14, 2025.
The sales were executed in multiple trades at weighted average prices of $152.57, $153.44, $154.27, and $155.20, with underlying trade ranges disclosed in the footnotes. Following these transactions, the reporting person directly owns 57,515 shares.
SNX filed a Form 144 notice for a proposed sale under Rule 144. The filing lists 504 common shares to be sold with an aggregate market value of 78,870.96, through Morgan Stanley Smith Barney LLC, on the NYSE with an approximate sale date of 11/03/2025. The shares were acquired as Restricted Stock Awards on 05/31/2025.
Shares outstanding were 81,437,855 at the time of the notice; this is a baseline figure, not the amount being offered.
TD SYNNEX (SNX) reported an insider transaction by a company officer (President, Europe). On 10/31/2025, the officer sold 1,573 shares at $156.49 and 100 shares at $156.52.
After these trades, the officer directly owned 16,529 shares of common stock, as reflected in the Form 4. The filing lists these as open-market sales and confirms direct ownership status.